Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > WARNING: Do NOT under sell your LABS shares. We have a

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Mar 25, 2024 10:01am

125 Views

Post# 35950520

WARNING: Do NOT under sell your LABS shares. We have a

real life comparable: Astrazeneca paid $21 per share for FUSN, a 'payload' delivery mechanism only.

If LABS only hits home runs on 25% their 'strong clinical trials', especially the cancer applications, this stock is worth AT LEAST as much as FUSN.

So WARNING: Do NOT sell your LABS stock at something like $7 and LEAVE a TON of money on the table.

This is the time you need to look deeper into the what the existing "unlocked" value of LABS is and make your financial plans accordingly.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages